Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Depreciation & Amortization (CF) (2016 - 2025)

Skinvisible's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $5118.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 13.79% year-over-year to $5118.0; the TTM value through Sep 2025 reached $20171.0, changed 0.18%, while the annual FY2024 figure was $20438.0, 8.88% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $5118.0 at Skinvisible, up from $5063.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5937.0 in Q3 2024 and bottomed at $4251.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $4729.0 (2022), against an average of $4789.8.
  • The largest annual shift saw Depreciation & Amortization (CF) tumbled 56.86% in 2021 before it soared 30.77% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $4695.0 in 2021, then rose by 0.92% to $4738.0 in 2022, then increased by 0.19% to $4747.0 in 2023, then rose by 6.38% to $5050.0 in 2024, then rose by 1.35% to $5118.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Depreciation & Amortization (CF) are $5118.0 (Q3 2025), $5063.0 (Q2 2025), and $4940.0 (Q1 2025).